Now · Care team

Dr. Ignatov

Dr. Rostislav Ignatov, MD

Role: Chief Medical Officer — The Haven Detox (West Palm Beach, FL)

Also functions as the psychiatric provider who will personally review Dad's medication regimen for fit (Lynn flagged this in her 2026-05-13 email).

Profile: havendetoxnow.com/dr-rostislav-ignatov

Credentials — strong fit for Dad's situation

  • MD — Florida State Medical License
  • Board-certified, General Psychiatry (ABPN — American Board of Psychiatry and Neurology)
  • Board-certified, Addiction Medicine (ABPM — American Board of Preventive Medicine)
  • 20+ years of clinical experience
  • Featured as an expert in 150+ news outlets on mental health and addiction treatment

The dual board certification (psychiatry + addiction medicine) is exactly the right credential set for Dad's case — heavy benzo + opioid history with co-occurring psychiatric features (Baker Act episode, current Zyprexa + Cymbalta regimen). Not all addiction-medicine doctors are also psychiatrists, and not all psychiatrists are addiction-medicine certified. He's both.

Training

  • Psychiatric Residency: University of Florida School of Medicine
  • Psychiatric Residency: Albert Einstein College of Medicine, New York
  • Fellowship: Child and Adolescent Psychiatry, University of Miami

Clinical specialties

  • Evidence-based psychiatric care
  • Addiction medicine
  • Complex dual-diagnosis cases
  • Treatment across developmental stages (children, adolescents, adults)

Role in Dad's care

Will personally review Dad's medication regimen for fit — Lynn flagged this as a key next step in her 2026-05-13 email:

"I will make sure that he sees Dr. Ignatov our head medical director who is also our psychiatric provider to go over the medication's and make sure that they are in fact a good fit for Paul."

Date for the consult is TBD; Lynn is arranging.

Contact

Questions to bring

Tier 1 — currently confirmed regimen:

  • Olanzapine (Zyprexa) dose, timing, and intended duration?
  • Duloxetine (Cymbalta) dose, timing, and primary indication (pain vs. depression vs. anxiety vs. some combination)?
  • SI + activation monitoring plan for the first ~2 weeks on duloxetine (FDA black-box, post–Baker Act context)?
  • BP cadence — duloxetine raises BP and Ross already flagged prior spikes?
  • EKG monitoring plan given CAD history (quad bypass) — Zyprexa carries QT risk; duloxetine adds modestly?
  • LFT recheck cadence on duloxetine?

Tier 2 — adjuncts we'd expect to see (hypothesis-generating; see medications page):

  • Is gabapentin in the regimen? (Near-standard adjunct in benzo withdrawal — surprising if not.)
  • Is clonidine in the regimen? Especially given Ross's BP-spike flag.
  • Was an anticonvulsant considered for kindling risk given 30y daily Xanax + prior cold-turkey?
  • Why olanzapine over quetiapine given Dad's metabolic baseline (insulin 57, A1c 5.8, LDL-P 1789, pattern B)?

Tier 3 — opioid side + Phase 2 planning:

  • Was buprenorphine offered at ER admission ~2026-04-25? If not, why?
  • Is naltrexone (oral or Vivitrol injection) on the table for Phase 2 relapse prevention?
  • Long-term exit plan for olanzapine and duloxetine (duloxetine notoriously hard to discontinue)?

Tier 4 — record + screening:

  • Document kindling risk in the permanent record (~30 years daily Xanax + prior cold-turkey event).
  • Bipolar screen given Baker Act + SNRI start?
  • Has the team seen Dad's 2025 baseline labs?
  • Plan and timeline for re-engaging EMDR therapy with Corrin?